IMPAACT4TB

Community statement: Introduction of child-friendly formulation of rifapentine for short-course TB preventive treatment

Safeguarding children against TB takes center stage with introduction of child-friendly formulation of rifapentine for short-course TB preventive treatment.

Read More →

New study: Combo treatment can help solve the TB-HIV co-infection crisis - more than half a million people could benefit

For people starting HIV treatment, combining dolutegravir-containing antiretroviral therapy with 3HP TB preventive treatment is safe and works effectively in tandem.

Read More →

#RightToPreventTB campaign: TB preventive treatment is a human right!

The #RightToPreventTB campaign focuses attention on the urgent need to scale-up TB preventive treatment as a matter of human rights.

Read More →

Calls for urgent action to address TB prevention deficits among children and household contacts of people affected by TB

IMPAACT4TB welcomes gains in TB prevention among people living with HIV, but calls for urgent action to address TB prevention deficits among children and household contacts of people affected by TB.

Read More →

Improving availability of patient-friendly TB preventive therapy

August 16, 2021: Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy (TPT).

Read More →

Ghana to administer new patient-friendly TB preventive therapy

Fixed-dose combination therapy reduces the weekly pill burden from nine to three for adults and prevents TB in those at highest risk of developing the disease.

Read More →

New patient-friendly TB preventive therapy to be rolled out in five high-burden TB countries at affordable price

-- Fixed-dose combination treatments reduce the pill burden from nine to three pills a week for adults and prevent TB in those at highest risk of developing the disease

-- Ethiopia, Ghana, Kenya, Mozambique, and Zimbabwe will be the first countries out of a total of 12 to provide the new regimen at a US$15 price thanks to funding from Unitaid, PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria

Read More →

Page 1 of 1 · Total posts: 7

1